Blastoschizomyces capitatus represents an emerging fungal pathogen in acute leukemia patients. The susceptibility to amphotericin B, 5-fluorocytosine, ketoconazole and fluconazole of nine clinical isolates was evaluated. A specific medium (high resolution medium) was used for testing fluconazole. This agent and 5-fluorocytosine were at least four- to eight-fold more active than amphotericin B and ketoconazole against all isolates but one.
|Numero di pagine||3|
|Rivista||Journal of Chemotherapy|
|Stato di pubblicazione||Pubblicato - 1991|
- Antifungal Agents
- Microbial Sensitivity Tests
- Mitosporic Fungi